Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
P-3073 in nail psoriasis
NCT03079973Phase 3Withdrawn
- Sponsor
- Polichem
- Start
- May 2017
- Primary completion
- Jul 2018
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in nail psoriasis comparing P-3073 with Vehicle (2 arms). Primary endpoint: Proportion of patients with clear target nail at Week 24. Planned start May 2017; status: withdrawn.
02
Drugs
calcipotriol
03
Conditions
nail psoriasis
Beyond the preview
Go deeper on NCT03079973.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03079973.